30
Participants
Start Date
July 31, 2009
Primary Completion Date
June 30, 2011
Study Completion Date
August 31, 2011
adalimumab
Injection of adalimumab (80 mg followed by 40 mg at week 1 and 40 mg EOW thereafter for 15 weeks)
UVB Phototherapy
This intervention can be applied alone or in combination with topical treatment. It will be performed between Day 0 and Day 112. The investigator is free to introduce or modify the topical and/or UVB regimens at any time after screening.
Topical treatment
"This intervention can be applied alone or in combination with UVB phototherapy. It will be performed between Day 0 and Day 112. The investigator is free to introduce or modify the topical and/or UVB regimens at any time after screening. The investigator will prescribe to patients randomized in this arm a select topical product from the list:~Calcipotriol, Calcipotriene, Dovonex, Tazorac, Tazarotene Anthralin, Corticosteroids."
Montreal Heart Institute, Montreal
Innovaderm Research Inc, Montreal
Lead Sponsor
Collaborators (1)
Abbott
INDUSTRY
Montreal Heart Institute
OTHER
Innovaderm Research Inc.
OTHER